⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1970431 | 1.00 | — | — | |
| SCHEMBL1405881 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2144603 | 0.98 | KDM4E (0.96) | — | |
| Hydrochloric Acid SCHEMBL4636135 | 0.98 | KDM4E (0.96) | — | |
| Hydrochloric Acid SCHEMBL2144598 | 0.98 | KDM4E (0.96) | — | |
| Hydrochloric Acid SCHEMBL4431863 | 0.98 | KDM4E (0.96) | — | |
| Hydrochloric Acid SCHEMBL3303102 | 0.98 | KDM4E (0.96) | — | |
| SCHEMBL5554688 | 0.93 | KDM4E (0.88) | — | |
| SCHEMBL4705489 | 0.93 | KDM4E (0.88) | — | |
| SCHEMBL29068616 | 0.91 | KDM4E (0.84) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2542 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616738-B2 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid | NOVO NORDISK A/S (DK) | 2026-05-05 | — | — | US | claimed |
| EP-4216955-B1 | ORAL COMPOSITIONS COMPRISING ANTAGONISTS THAT INHIBIT OR BLOCK NICOTINIC ACETYLCHOLINE RECEPTORS (NACHR) AND/OR TRANSIENTRECEPTOR POTENTIAL (TRP) ION CHANNELS FOR NICOTINE BURNING RELIEF | FERTIN PHARMA AS (DK) | 2026-04-08 | — | — | EP | claimed |
| EP-3886993-B1 | ORAL CARE IMPLEMENT HAVING A RELEASE COMPONENT | COLGATE PALMOLIVE CO (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260083751-A1 | ALLOSTERIC MODULATORS OF ANDROGEN RECEPTOR COACTIVATOR RECRUITMENT FOR CRPC THERAPY | UNIVERSITY OF PITTSBURGH – OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2026-03-26 | — | — | US | claimed |
| EP-3843845-B1 | INHIBITION OF PROTEIN KINASES TO TREAT FRIEDREICH ATAXIA | UNIV MASSACHUSETTS (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4436667-B1 | PIPERAZINYLSULFONYLARYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS | HOFFMANN LA ROCHE (CH) | 2026-01-21 | — | — | EP | claimed |
| EP-3455204-B1 | CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS | Jubilant Epicore LLC (US) | 2025-10-29 | — | — | EP | claimed |
| EP-3817575-B1 | SOLUBILISATION OF COOLING AGENTS OF LOW SOLUBILITY | SYMRISE AG (DE) | 2025-10-15 | — | — | EP | claimed |
| EP-4301736-B1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2025-10-08 | — | — | EP | claimed |
| EP-3886994-B1 | ORAL CARE IMPLEMENT HAVING A RELEASE COMPONENT | COLGATE PALMOLIVE CO (US) | 2025-10-08 | — | — | EP | claimed |
| WO-2002011710-A2 | PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | PFIZER PRODUCTS INC. (US) | 2002-02-14 | — | — | WO | claimed |
| CN-1335883-A | Laundry and Cleaning Compositions | PROCTER & GAMBLE (US) | 2002-02-13 | — | — | CN | claimed |
| WO-2001070673-A2 | CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-09-27 | — | — | WO | claimed |
| EP-0221572-B1 | N-SUBSTITUTED 3-PIPERIDINE-OR 3-PYRIDINE-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | WARNER-LAMBERT COMPANY (US) | 1991-09-25 | — | — | EP | claimed |
| US-4910312-A | Containing 1-(2-(bis((4-trifluoromethylphenyl)methoxy)-ethyl)-substitution | WARNER-LAMBERT COMPANY (US) | 1990-03-20 | — | — | US | claimed |
| EP-0346927-A2 | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridine-carboxylic acids and derivatives thereof | WARNER-LAMBERT COMPANY (US) | 1989-12-20 | — | — | EP | claimed |
| US-4772615-A | ANTICONVULSANT FOR TREATING EPILEPSY | WARNER-LAMBERT COMPANY (US) | 1988-09-20 | — | — | US | claimed |
| EP-0221572-A2 | N-substituted 3-piperidine-or 3-pyridine-carboxylic acids and derivatives thereof | WARNER-LAMBERT COMPANY (US) | 1987-05-13 | — | — | EP | claimed |
| CN-86107695-A | The 3-piperidine carboxylic acid of different nitrogen-replacements or the 3-pyridine carboxylic acid of nitrogen-replacement and their derivative | — | 1987-05-13 | — | — | CN | claimed |
| US-4599419-A | ANTICOAGULANTS | MITSUBISHI CHEMICAL INDUSTRIES, INC. (JP) | 1986-07-08 | — | — | US | claimed |